Hospital
North Oak Regional Hospital INC
North Oak Regional Hospital INC was paid $615K by Medicaid between Jan 2018 and Apr 2019, across 73 billing codes. Its largest line is 99283, emergency room visit (moderate) — 13% of everything it billed.
33Billing provider infoNORTH OAK REGIONAL HOSPITAL INC
SENATOBIA, MS 38668
SENATOBIA, MS 38668
33aNPI1205811304assigned 12/12/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$615K
24GClaims24,818
24DCodes billed73
24AFirst – last monthJan 2018 – Apr 2019
Compared with peers
Next to other General Acute Care Hospital providers in Mississippi
Rank by total paid#54 of 77
Median peer was paid$8.23M
This provider vs. median0.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 24,319 | $604K | |
| 2019 | 499 | $12K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 13% | 1,282 | 850 | $77K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 12% | 588 | 424 | $75K |
| G0378 | Hospital observation service, per hour | 7.6% | 233 | 107 | $47K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7.2% | 201 | 151 | $44K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.1% | 2,081 | 1,433 | $44K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 7.1% | 547 | 468 | $44K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.0% | 661 | 479 | $37K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.9% | 1,785 | 909 | $30K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4.3% | 466 | 402 | $26K |
| 97597 | 4.0% | 688 | 275 | $25K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 3.2% | 312 | 145 | $20K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.4% | 616 | 410 | $15K |
61 more codes
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2.4% | 1,449 | $15K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.5% | 102 | $9K |
| 80053 | Comprehensive metabolic panel | 1.5% | 1,075 | $9K |
| 71046 | Radiologic examination, chest; 2 views | 1.3% | 326 | $8K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.3% | 91 | $8K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.2% | 1,286 | $8K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.1% | 126 | $7K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.0% | 284 | $6K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 213 | $5K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 141 | $5K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 505 | $5K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 317 | $4K |
| 72100 | <1% | 77 | $3K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 54 | $3K |
| 80061 | Lipid panel | <1% | 292 | $3K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 246 | $2K |
| 80305 | <1% | 427 | $2K | |
| 81025 | <1% | 606 | $2K | |
| 84484 | <1% | 237 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,878 | $2K |
| 97602 | <1% | 46 | $2K | |
| 20610 | <1% | 69 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 120 | $2K |
| 73560 | <1% | 56 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 253 | $2K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 55 | $2K |
| 81000 | <1% | 630 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 204 | $1K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 88 | $1K |
| 87070 | <1% | 145 | $1K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 46 | $722.63 |
| 72170 | <1% | 17 | $656.59 | |
| 83735 | <1% | 124 | $620.25 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 18 | $600.21 |
| 83690 | <1% | 93 | $547.34 | |
| 87205 | <1% | 145 | $541.92 | |
| 99217 | <1% | 15 | $465.75 | |
| 71045 | Radiologic examination, chest; single view | <1% | 18 | $458.09 |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 24 | $410.19 |
| 83037 | <1% | 72 | $358.96 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 473 | $353.87 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 474 | $243.98 |
| J3300 | Injection, triamcinolone acetonide, preservative free, 1 mg | <1% | 97 | $238.11 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 311 | $230.52 |
| 82948 | <1% | 110 | $158.44 | |
| 81002 | <1% | 61 | $134.30 | |
| 85610 | <1% | 53 | $124.90 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 17 | $97.10 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 605 | $95.14 |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 15 | $73.63 |
| 85730 | <1% | 21 | $66.04 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 163 | $27.41 |
| 94760 | <1% | 330 | $18.00 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 47 | $2.48 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 38 | $0.96 |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | 0% | 70 | $0.00 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 26 | $0.00 |
| J3490 | Unclassified drugs | 0% | 114 | $0.00 |
| 99406 | 0% | 85 | $0.00 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 215 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 63 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGRAHAM, SONJA (CHEIF EXECUTIVE OFFICER)
Parent organizationNORTH OAK REGIONAL HOSPITAL INC